Fig. 2From: An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countriesFlow diagram of drugs for rare diseases in the access pathway in Canada. CADTH, Canadian Agency for Drugs and Technologies in Health; INESSS, Institut National d'Excellence en Santé et Services Sociaux; recs, recommendationsBack to article page